Conference Coverage

New research holds promise for fighting obesity, says expert


 

AT INTERNAL MEDICINE 2022

Medication costs are too high for many patients

Isis Smith, MD, an internist at University Medical Center in New Orleans, said in an interview that the cost of the most effective medications – which are not covered by Medicaid – means that many of her patients don’t have access to these treatments.

“We’re talking about $1,000 a month. And so there is no way they can afford [them]. I can prescribe phentermine [but] unless a patient has another indication, Medicaid will not pay for it,” she explained.

“I love hearing about all of the new developments. ... It’s interesting to hear, but we need to get insurance to pay so that I can actually prescribe,” Dr. Smith noted.

Dr. Apovian reports financial relationships with Xeno Biosciences, Cowen, Allergan, Novo Nordisk, Abbott Nutrition, and other companies.

Pages

Recommended Reading

Hypertension control during pregnancy validated in major trial
MDedge Endocrinology
Type 2 diabetes remission possible for those with lower BMI
MDedge Endocrinology
AHA statement addresses CVD risk in NAFLD
MDedge Endocrinology
Bariatric surgery cuts cardiovascular events, even in seniors
MDedge Endocrinology
Study: Fasting plus calorie counting offered no weight-loss benefit over calorie counting alone
MDedge Endocrinology
Depression strikes more than half of obese adolescents
MDedge Endocrinology
Water, water everywhere leads to leaner students
MDedge Endocrinology
Endoscopic obesity treatments offer alternatives to surgery
MDedge Endocrinology
It’s time to shame the fat shamers
MDedge Endocrinology
Tirzepatide succeeds in obesity in SURMOUNT-1, says Lilly
MDedge Endocrinology